Wall Street Bigwigs Are Talking About a Big Pullback in Stocks. Should You Be Worried?
Investopedia· 2025-11-04 19:45
David Solomon, CEO of Goldman Sachs, during the Global Financial Leaders' Investment Summit in Hong Kong. Lam Yik / Bloomberg via Getty Images Close Key Takeaways Some big Wall Street bosses see a stock pullback coming. That doesn't mean they're panicking. Goldman Sachs CEO David Solomon and Ted Pick, of Morgan Stanley, spoke Tuesday during a panel in Hong Kong. Solomon said a 10% to 20% drawdown in equity markets was "likely" in the "next 12 to 24 months," while Pick suggested that investors should "welcom ...
JPMorgan says these two are the best stocks to own in November

Invezz· 2025-11-04 19:45
JPMorgan has refreshed its analyst-curated focus list, spotlighting two standout names – Alphabet Inc (NASDAQ: GOOGL) and Alkami Technology Inc (NASDAQ: ALKT). The bank's monthly update reflects top p... ...
Pfizer, Novo Nordisk Intensify Fight For Metsera As Buyout Offers Continue To Climb


Benzinga· 2025-11-04 19:45
Adding more drama to Metsera Inc.’s (NASDAQ:MTSR) acquisition deal, Novo Nordisk A/S (NYSE:NVO) increased the deal proposal to $62.20 per share in cash, up from $56.50. • Watch the MTSR momentum here.Metsera said the amended proposal constitutes a “Superior Company Proposal.”Additionally, Metsera would issue Novo Nordisk non-voting preferred stock representing 50% of Metsera’s share capital.On the same day, Metsera would declare a dividend of $62.20 per share in cash (up from $56.50).Metsera shareholders co ...
Here's What Wall Street Analysts Are Saying About Palantir's Earnings as Its Stock Plunges
Investopedia· 2025-11-04 19:45
Core Insights - Palantir is experiencing significant growth driven by demand for its Artificial Intelligence Platform from both companies and governments [1] Company Performance - The CEO highlighted that the growth is described as "otherworldly," indicating an exceptional increase in interest and usage of their software solutions [1] Market Demand - There is a notable surge in demand for data analytics software, particularly in the context of AI, as organizations seek to leverage advanced technologies for better decision-making [1]
Murphy Oil to Post Q3 Earnings: What's in Store this Season?
ZACKS· 2025-11-04 19:41
Key Takeaways Murphy Oil expects Q3 revenues of $664.74M, down 12.35% year over year.Production is projected at 185-193 Mboe/d, supported by domestic and international assets.Higher output, cost control and buybacks are expected to aid MUR's bottom line.Murphy Oil Corporation (MUR) is expected to register a year-over-year decline in both top and bottom lines when it reports third-quarter 2025 results on Nov. 5, after market close. The company reported an earnings surprise of 28.57% in the last reported quar ...
Kirby Q3 Earnings Surpass Estimates, Increase Year Over Year
ZACKS· 2025-11-04 19:41
Key Takeaways Kirby's Q3 EPS of $1.65 topped estimates and rose 6.5% year over year on higher revenues.Coastal marine and power generation strength drove gains despite inland softness.KEX repurchased $120M in shares and generated $227.5M in operating cash flow.Kirby Corporation (KEX) reported third-quarter 2025 earnings of $1.65 per share, which surpassed the Zacks Consensus Estimate of $1.60 and improved 6.5% year over year. Total revenues of $871.2 million missed the Zacks Consensus Estimate of $888.3 mil ...
American Airlines to cut hundreds of jobs at Fort Worth Headquarters in Texas following Q3 loss
MINT· 2025-11-04 19:40
American Airlines Group Inc. is laying off hundreds of corporate employees after reporting a third-quarter loss, Bloomberg reported, citing a person familiar with the matter.The cuts will primarily affect mid-management and support staff based at the airline’s headquarters in Fort Worth, Texas, and are set to begin this week.“We’re making a small reduction to our management and support staff team to right-size for the work we do today,” an American Airlines spokesperson said in a statement. “The positions a ...
Qualcomm Set To Supply 90% Of iPhone 17 Modems, Analyst Says
Benzinga· 2025-11-04 19:38
Core Viewpoint - Qualcomm Inc is positioned for near-term growth due to strong smartphone demand, increased chip share in Apple's iPhone 17, and expanding opportunities in AI [1][2][3] Group 1: Financial Projections - Analyst Samik Chatterjee maintains an Overweight rating on Qualcomm, raising the price forecast from $200 to $210 [2] - For fiscal Q4 2025, projected revenue is $10.9 billion, exceeding consensus of $10.7 billion, with adjusted EPS of $2.90 compared to $2.85 consensus [6] - For fiscal Q1 2026, anticipated revenue is $11.9 billion, above the Street's $11.6 billion view, with EPS of $3.34 versus expectations of $3.25 [7] Group 2: Market Position and Trends - Qualcomm's modem share in new iPhones is expected to reach about 90%, up from a previous estimate of 70%, due to limited impact from Apple's in-house modem [5] - Handset revenue is projected to increase by 7% quarter-over-quarter, driven by robust smartphone demand and higher market share with Apple [6] Group 3: Segment Performance - The automotive and IoT segments are expected to grow more than 20% in fiscal 2026, contributing to revenue diversification [9] - Qualcomm's AI datacenter products (AI200 and AI250) are highlighted as key growth catalysts, with data center revenue projected to reach $1.4 billion by fiscal 2027 [9] Group 4: Competitive Landscape - Qualcomm's share of Samsung's flagship devices is expected to return to approximately 70%, which may lead to a revenue decline to $10.6 billion in a future quarter [8] - The company faces potential headwinds of $800 million in fiscal Q2 2026 due to Samsung reintroducing its in-house Exynos chipsets [7]
Ionis: What Upside Is Left After Shares Rocketed Higher After Positive Trial Data? (IONS)
Seeking Alpha· 2025-11-04 19:38
Ionis Pharmaceuticals, Inc. ( IONS ) just released very positive trial data from phase-3 studies in their pipeline drugs, and the share price responded very positively, rising 80% or so since the news broke. This is phenomenal, but itI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I believe ...
Ionis: What Upside Is Left After Shares Rocketed Higher Following Positive Trial Data?
Seeking Alpha· 2025-11-04 19:38
Ionis Pharmaceuticals, Inc. ( IONS ) just released very positive trial data from phase-3 studies in their pipeline drugs, and the share price responded very positively, rising 80% or so since the news broke. This is phenomenal, but itI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I believe ...